• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲 COVID-19 病例、病死率和治愈率的增加:一项跨时间的荟萃分析。

Increase in COVID-19 cases and case-fatality and case-recovery rates in Europe: A cross-temporal meta-analysis.

机构信息

Akdeniz University, Kampus, Antalya, 07070, Turkey.

出版信息

J Med Virol. 2020 Sep;92(9):1511-1517. doi: 10.1002/jmv.26035. Epub 2020 Jun 2.

DOI:10.1002/jmv.26035
PMID:32437052
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7280723/
Abstract

The new coronavirus (COVID-19) infection reported in China in December 2019 has become a pandemic in a few weeks, affecting the entire world. In this respect, it is crucial to determine the case-increase, case-fatality, and case-recovery rates to control COVID-19. In this study, the case-increase, case-fatality, and case-recovery rates of COVID-19 in 36 European countries were analyzed with the meta-analysis method using data released by the health organizations and WHO. The data were obtained from the website of health organizations of 36 European countries and the website of WHO until 11 May 2020. The analyses were carried out on 1 744 704 COVID-19-diagnosed cases in 36 European countries. The case-increase, case-fatality and case-recovery rates of COVID-19 were calculated using 95% confidence intervals (95% CI), single-arm meta-analysis, cross-temporal meta-analysis, and meta-regression random-effects model. The standardized case-increase rate of COVID-19 is 5% (95% CI [0.040, 0.063]) and the average case-increase rate in European countries has started to decline by around 3% (95% CI [0.047, 0.083]) weekly. The countries with the highest rate of case increase are Belgium, Sweden, Russia, the Netherlands and the United Kingdom. Although the case-fatality rate of COVID-19 patients was 4.5% as of May 11 (95% CI [0.037-0.055]), this rate is 6.3% (95% CI [0.047, 0.083]) in standardized time (6th week). The case-recovery rates of patients are 46% (95% CI [0.376-0.547]). This study presents important results regarding the COVID-19 pandemic in Europe. Although the rate of increase in new COVID-19 cases has dropped, there is not much decline in the case-fatality rates and no increase in case-recovery rates. The case-fatality rate of COVID-19 in Europe was estimated to be in the range of 4% to 4.5% and a minimum of 4 weeks (as of 11 May) is expected to have the figure below 1% in a country with an average case-increase rate. Monitoring case fatalities in Belgium, the Netherlands and Sweden, and treatment successes in Germany and Austria play a role of utmost importance.

摘要

2019 年 12 月在中国报告的新型冠状病毒(COVID-19)感染已在数周内成为大流行,影响了整个世界。在这方面,确定病例增长率、病死率和病例治愈率对于控制 COVID-19 至关重要。在这项研究中,使用卫生组织发布的数据,采用荟萃分析方法分析了 36 个欧洲国家的 COVID-19 病例增长率、病死率和治愈率。数据来自 36 个欧洲国家卫生组织的网站和世卫组织的网站,直至 2020 年 5 月 11 日。对 36 个欧洲国家的 1744704 例 COVID-19 确诊病例进行了分析。使用 95%置信区间(95%CI)、单臂荟萃分析、跨时间荟萃分析和荟萃回归随机效应模型计算 COVID-19 的病例增长率、病死率和治愈率。COVID-19 的标准化病例增长率为 5%(95%CI [0.040,0.063]),欧洲国家的平均病例增长率每周下降约 3%(95%CI [0.047,0.083])。病例增长率最高的国家是比利时、瑞典、俄罗斯、荷兰和英国。尽管截至 5 月 11 日 COVID-19 患者的病死率为 4.5%(95%CI [0.037-0.055]),但标准化时间(第 6 周)的病死率为 6.3%(95%CI [0.047,0.083])。患者的病例治愈率为 46%(95%CI [0.376-0.547])。本研究提供了有关欧洲 COVID-19 大流行的重要结果。尽管新的 COVID-19 病例增长率有所下降,但病死率下降幅度不大,病例治愈率也没有增加。欧洲 COVID-19 的病死率估计在 4%至 4.5%之间,预计在平均病例增长率较低的国家,至少在 4 周(截至 5 月 11 日)后病死率将低于 1%。监测比利时、荷兰和瑞典的病死率以及德国和奥地利的治疗成功情况至关重要。

相似文献

1
Increase in COVID-19 cases and case-fatality and case-recovery rates in Europe: A cross-temporal meta-analysis.欧洲 COVID-19 病例、病死率和治愈率的增加:一项跨时间的荟萃分析。
J Med Virol. 2020 Sep;92(9):1511-1517. doi: 10.1002/jmv.26035. Epub 2020 Jun 2.
2
Effect of heat and humidity on the incidence and mortality due to COVID-19 pandemic in European countries.热湿对欧洲国家 COVID-19 大流行发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(17):9216-9225. doi: 10.26355/eurrev_202009_22874.
3
Surveillance of the Second Wave of COVID-19 in Europe: Longitudinal Trend Analyses.欧洲 COVID-19 第二波疫情监测:纵向趋势分析。
JMIR Public Health Surveill. 2021 Apr 28;7(4):e25695. doi: 10.2196/25695.
4
Comparing the COVID-19 pandemic in space and over time in Europe, using numbers of deaths, crude rates and adjusted mortality trend ratios.比较欧洲在不同时期和空间下的 COVID-19 疫情,使用死亡人数、粗死亡率和调整后的死亡率趋势比。
Sci Rep. 2021 Aug 12;11(1):16443. doi: 10.1038/s41598-021-95658-4.
5
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
6
Coronavirus disease 2019 and gender-related mortality in European countries: A meta-analysis.2019 年冠状病毒病与欧洲国家的性别相关死亡率:一项荟萃分析。
Maturitas. 2020 Nov;141:59-62. doi: 10.1016/j.maturitas.2020.06.017. Epub 2020 Jun 23.
7
Older age groups and country-specific case fatality rates of COVID-19 in Europe, USA and Canada.欧洲、美国和加拿大的 COVID-19 年龄较大人群和特定国家的病死率。
Infection. 2021 Feb;49(1):111-116. doi: 10.1007/s15010-020-01538-w. Epub 2020 Oct 24.
8
COVID-19, Australia: Epidemiology Report 18 (Fortnightly reporting period ending 7 June 2020).澳大利亚2019冠状病毒病:流行病学报告18(截至2020年6月7日的两周报告期)
Commun Dis Intell (2018). 2020 Jun 17;44. doi: 10.33321/cdi.2020.44.52.
9
Country-level determinants of the severity of the first global wave of the COVID-19 pandemic: an ecological study.国家层面因素对 COVID-19 大流行首个全球浪潮严重程度的影响:一项生态学研究。
BMJ Open. 2021 Feb 3;11(2):e042034. doi: 10.1136/bmjopen-2020-042034.
10
Epidemiological trends in COVID-19 pandemic: prospective critical appraisal of observations from six countries in Europe and the USA.COVID-19 大流行的流行病学趋势:对欧洲和美国六个国家的观察结果进行前瞻性批判性评价。
BMJ Open. 2021 Apr 8;11(4):e045782. doi: 10.1136/bmjopen-2020-045782.

引用本文的文献

1
Improving long COVID-related text classification: a novel end-to-end domain-adaptive paraphrasing framework.改善与长新冠相关的文本分类:一种新颖的端到端领域自适应释义框架。
Sci Rep. 2024 Jan 2;14(1):85. doi: 10.1038/s41598-023-48594-4.
2
Making "Joy Pie" to Stay Joyful: Self-Care Interventions Alleviate College Students' Mental Health Challenges.制作“快乐派”以保持快乐:自我保健干预减轻大学生心理健康挑战。
Int J Environ Res Public Health. 2023 Feb 21;20(5):3823. doi: 10.3390/ijerph20053823.
3
Time-series comparison of COVID-19 case fatality rates across 21 countries with adjustment for multiple covariates.对21个国家的新冠病毒疾病病死率进行时间序列比较,并对多个协变量进行调整。
Osong Public Health Res Perspect. 2022 Dec;13(6):424-434. doi: 10.24171/j.phrp.2022.0212. Epub 2022 Nov 28.
4
Effects of Adding an Online Exercise Program on Physical Function in Individuals Hospitalized by COVID-19: A Randomized Controlled Trial.添加在线运动方案对因 COVID-19 住院个体身体功能的影响:一项随机对照试验。
Int J Environ Res Public Health. 2022 Dec 10;19(24):16619. doi: 10.3390/ijerph192416619.
5
Global variations in the burden of SARS-CoV-2 infection and its outcomes in pregnant women by geographical region and country's income status: a meta-analysis.全球不同地理区域和国家收入状况下 SARS-CoV-2 感染及其母婴结局的负担:一项荟萃分析。
BMJ Glob Health. 2022 Nov;7(11). doi: 10.1136/bmjgh-2022-010060.
6
Comparison of clinical characteristics between SARS-CoV-2 Omicron variant and Delta variant infections in China.中国新冠病毒奥密克戎变异株与德尔塔变异株感染的临床特征比较。
Front Med (Lausanne). 2022 Oct 12;9:944909. doi: 10.3389/fmed.2022.944909. eCollection 2022.
7
Genomic Surveillance of SARS-CoV-2 in the Southern Province of Zambia: Detection and Characterization of Alpha, Beta, Delta, and Omicron Variants of Concern.赞比亚南部省份 SARS-CoV-2 的基因组监测:关注的 Alpha、Beta、Delta 和奥密克戎变异株的检测和特征分析。
Viruses. 2022 Aug 24;14(9):1865. doi: 10.3390/v14091865.
8
Individual Freedom in the Initial Response to Covid-19.个体在应对新冠疫情初期的自由。
Front Public Health. 2022 Jun 3;10:765016. doi: 10.3389/fpubh.2022.765016. eCollection 2022.
9
Characteristics, complications, and a comparison between early and late tracheostomy: A retrospective observational study on tracheostomy in patients with COVID-19-related acute respiratory distress syndrome.特征、并发症以及早期与晚期气管切开术的比较:一项关于新型冠状病毒肺炎相关急性呼吸窘迫综合征患者气管切开术的回顾性观察研究
Health Sci Rep. 2022 Apr 22;5(3):e595. doi: 10.1002/hsr2.595. eCollection 2022 May.
10
SARS-CoV-2: Evolution and Emergence of New Viral Variants.SARS-CoV-2:病毒新变体的进化和出现。
Viruses. 2022 Mar 22;14(4):653. doi: 10.3390/v14040653.

本文引用的文献

1
COVID-19 in Colombia endpoints. Are we different, like Europe?哥伦比亚的 COVID-19 终点。我们和欧洲不一样吗?
Res Social Adm Pharm. 2021 Jan;17(1):2036-2039. doi: 10.1016/j.sapharm.2020.03.013. Epub 2020 Mar 31.
2
Monitoring transmissibility and mortality of COVID-19 in Europe.监测欧洲 COVID-19 的传染性和死亡率。
Int J Infect Dis. 2020 Jun;95:311-315. doi: 10.1016/j.ijid.2020.03.050. Epub 2020 Mar 28.
3
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
4
Coronavirus Disease 2019 (COVID-19) in Italy.意大利的2019冠状病毒病(COVID-19)。
JAMA. 2020 Apr 14;323(14):1335. doi: 10.1001/jama.2020.4344.
5
COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.COVID-19 患者的临床特征、出院率和死亡率的荟萃分析。
J Med Virol. 2020 Jun;92(6):577-583. doi: 10.1002/jmv.25757. Epub 2020 Mar 23.
6
The reproductive number of COVID-19 is higher compared to SARS coronavirus.与严重急性呼吸综合征冠状病毒相比,新型冠状病毒肺炎的繁殖数更高。
J Travel Med. 2020 Mar 13;27(2). doi: 10.1093/jtm/taaa021.
7
Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province.湖北省三级医院新型冠状病毒病例的临床特征。
Chin Med J (Engl). 2020 May 5;133(9):1025-1031. doi: 10.1097/CM9.0000000000000744.
8
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study.实时预测和预报源自中国武汉的 2019-nCoV 疫情在国内和国际的潜在传播:一项建模研究。
Lancet. 2020 Feb 29;395(10225):689-697. doi: 10.1016/S0140-6736(20)30260-9. Epub 2020 Jan 31.
9
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
10
From SARS to MERS, Thrusting Coronaviruses into the Spotlight.从 SARS 到 MERS,冠状病毒备受瞩目。
Viruses. 2019 Jan 14;11(1):59. doi: 10.3390/v11010059.